Pfizer Set to Acquire Hospira

Pfizer announced in a press release that “they have entered into a definitive merger agreement under which Pfizer will acquire Hospira, the world’s leading provider of injectable drugs and infusion technologies and a global leader in biosimilars, for $90 a share...

House Bill Would Speed Drug Approvals, Boost Research

In a recent article from the New York Times, drug approvals could have a faster turnaround if a new bill passes through the House of Representatives. According to the article, “Urged on by the medical industry and patients’ groups, the House overwhelmingly...

Medical Device Maker ResMed Acquires CareTouch

“Sleeping disorder device-maker ResMed, has acquired Westminster-based CareTouch, a medical equipment resupply and health information communications firm, officials announced Wednesday,” according to an article from San Diego Business Journal.  For more...

ICYMI: Lima Corporate closes Zimmer Biomet acquisitions

In an article via MassDevice.com, “Lima Corporate said last Friday that it has completed its acquisition of knee and elbow assets from the merged Zimmer and Biomet. The Italian orthopedic company said it purchased Zimmer’s unicompartmental High Flex knee implant...

Global Health: A Scientific Ethical Divide Between China and West

“China is spending hundreds of billions of dollars annually in an effort to become a leader in biomedical research, building scores of laboratories and training thousands of scientists,” according to the New York Times.  “But the rush to the front...